Savior LLC Valneva Se Transaction History
Savior LLC
- $17.4 Million
- Q4 2024
Shares
1 transactions
Others Institutions Holding VALN
# of Institutions
13Shares Held
719KCall Options Held
0Put Options Held
0-
General American Investors CO Inc354KShares$2.39 Million0.11% of portfolio
-
Wells Fargo & Company San Francisco, CA247KShares$1.67 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il69.5KShares$469,1110.0% of portfolio
-
Ironwood Investment Management LLC Boston, MA25KShares$168,8980.06% of portfolio
-
Abc Arbitrage Sa Paris, I019.2KShares$129,8970.01% of portfolio
About Valneva SE
- Ticker VALN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,103,504
- Market Cap $466M
- Description
- Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...